Literature DB >> 9299578

Basic science aspects of prostate cancer.

T J Dorkin1, D E Neal.   

Abstract

Prostate cancer carries significant morbidity and mortality, but its outcome is difficult to predict in the individual. Androgen ablation delays progression in men, but hormone resistance soon develops and much basic science research has focused on how prostate cancer 'escapes' hormonal control. Stem cell models of prostate development and homeostasis have been proposed, but have not yet been fully characterized. Some androgen-regulated signalling pathways and abnormalities that affect them have been defined recently. It is apparent that locally produced growth factors, often regulated by androgens, exert an effect both physiologically and pathologically and these too will be discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299578     DOI: 10.1006/scbi.1997.0049

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  11 in total

1.  Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8.

Authors:  Yohko Yamazaki; Tetsuya Someno; Masayuki Igarashi; Naoko Kinoshita; Masaki Hatano; Manabu Kawada; Isao Momose; Akio Nomoto
Journal:  J Antibiot (Tokyo)       Date:  2014-10-01       Impact factor: 2.649

2.  Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.

Authors:  S Ross; S D Spencer; L A Lasky; H Koeppen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer.

Authors:  Z Kolár; P G Murray; K Scott; A Harrison; B Vojtĕsek; J Dusek
Journal:  Mol Pathol       Date:  2000-02

4.  Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus.

Authors:  Steven M Markus; Samir S Taneja; Susan K Logan; Wenhui Li; Susan Ha; Adam B Hittelman; Inez Rogatsky; Michael J Garabedian
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

5.  Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.

Authors:  S M Goodyear; M D Amatangelo; M E Stearns
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

6.  Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.

Authors:  J Mad'arová; M Lukesová; A Hlobilková; M Strnad; B Vojtesek; R Lenobel; M Hajdúch; P G Murray; S Perera; Z Kolár
Journal:  Mol Pathol       Date:  2002-08

Review 7.  8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.

Authors:  Veda Prachayasittikul; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Drug Des Devel Ther       Date:  2013-10-04       Impact factor: 4.162

8.  Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.

Authors:  R Mukherjee; D H McGuinness; P McCall; M A Underwood; M Seywright; C Orange; J Edwards
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

9.  4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.

Authors:  Mingyang Cai; Sewoon Kim; Kai Wang; Peggy J Farnham; Gerhard A Coetzee; Wange Lu
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

10.  Synthesis and PI3 Kinase Inhibition Activity of Some Novel Trisubstituted Morpholinopyrimidines.

Authors:  Emily W Wright; Ronald A Nelson; Yelena Karpova; George Kulik; Mark E Welker
Journal:  Molecules       Date:  2018-07-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.